Studienserver - Medizinische Hochschule Hannover

Studien: AP 12009 in patients with recurrent/refractory anaplastic astrocytoma (SAPPHIRE)

ID Studie

AP 12009-G005

EudraCT-Nummer

2007-005802-38

Clinicaltrials.gov Identifier

NCT00761280

Beschreibung

A multinational phase III study to compare the efficacy and safety of 10 µM AP 12009 to standard chemotherapy (temozolomide or BCNU) in adult patients with confirmed recurrent or refractory anaplastic astrocytoma (WHO grade III).

Status

aktiv